Effect of saline perfusion before catheter removal in patients with BPH treated with GreenLight laser photoselective vaporization of the prostate.

OBJECTIVE: To investigate the effect of saline perfusion before catheter removal in patients with benign prostatic hyperplasia (BPH) treated with GreenLight laser photoselective vaporization of the prostate (PVP). MATERIALS AND METHODS: Patients (n=200) with BPH treated with PVP were divided into perfusion (n=100) and control (n=100) groups. For the perfusion group, saline (200 mL or the maximum capacity tolerated) was irrigated into the bladder after standardized external urethral disinfection, and the catheter was removed. Catheter removal was routinely performed in the control group. Perioperative adverse events and clinical outcomes were compared between the groups. RESULTS: Patients in the perfusion group had a shorter waiting time [3 (0-4) vs. 15 (8.75-26) min; P<0.001] and a better satisfaction grade [24 (21.75-26) vs. 23 (20-25); P=0.016] for first urination than those in the control group. The perfusion group exhibited lower anxiety levels regarding first urination than the control group [1 (1-2) vs. 1.5 (1-2), respectively; P=0.012]. Urinalysis revealed that the perfusion group had significantly lower white blood cell (WBC) count than the control group on the day [25.5 (8-37.75) vs. 43.5 (24.0-64.75); P<0.001] and 2 weeks [20.5 (11-27) vs. 31.0 (20-42); P<0.001] after catheter removal. No significant differences in treatment-related adverse events were observed [perfusion (n=15), control (n=20)]. CONCLUSION: Saline perfusion before catheter removal in patients with BPH treated with PVP could shorten the waiting time for first urination, improve patient anxiety and satisfaction and reduce postoperative urinary WBC levels.

Lamin B1 promotes tumor progression and metastasis in primary prostate cancer patients.

Aims: To determine the role of lamin B1 (LMNB1) in the progression and metastasis of primary prostate cancer (PC). Patients & methods: Two PC cohorts were used to investigate the clinical relationship between LMNB1 expression and tumor progression and metastasis. Results: The qRT-PCR results revealed that LMNB1 expression was markedly increased in patients with aggressive features and was associated with worse prognosis. Logistic regression analyses indicated that LMNB1 expression is an independent risk factor for distant metastasis. Kaplan-Meier analysis showed that increased LMNB1 levels were related to poor disease-free survival in the primary PC cohort. Conclusion: This study reveals that upregulation of LMNB1 is associated with cancer metastasis and poor survival outcomes in primary PC patients.

Construction of Oxygen-Rich Carbon Foams for Rapid Carbon Dioxide Capture.

As carbon dioxide (CO2) adsorbents, porous materials with high specific surface areas and abundant CO2-philic groups always exhibit high CO2 capacities. Based on this consensus, a category of oxygen-rich macroporous carbon foams was fabricated from macroporous resorcinol-formaldehyde resins (PRFs), which were obtained via an oil-in-water concentrated emulsion. By the active effect of potassium hydroxide (KOH) at high temperatures, the resultant carbon foams (ACRFs) possessed abundant micropores with rich oxygen content simultaneously. At the same time, most of the ACRFs could retain the marcoporous structure of their precursor. It is found that porosity of ACRFs was mainly determined by carbonization temperature, and the highest specific surface areas and total pore volume of ACRFs could reach 2046 m2/g and 0.900 cm3/g, respectively. At 273 k, ACRFs showed highest CO2 capacity as 271 mg/g at 1 bar and 91.5 mg at 15 kPa. Furthermore, it is shown that the ultra-micropore volume was mainly responsible for the CO2 capacities of ACRFs at 1 bar, and CO2 capacities at 15 kPa were mainly affected by the oxygen content. It is also found that the presence of macropores would accelerate ACRFs adsorbing CO2. This study provides ideas for designing a porous CO2 adsorbent.

Nitrogen-Doped Ketjenblack Carbon Supported Co3O4 Nanoparticles as a Synergistic Electrocatalyst for Oxygen Reduction Reaction.

Developing a highly active and cost-effective cathode electrocatalyst with strong stability for oxygen reduction reaction (ORR) is extremely necessary. In this work, we reported a facile synthetic path to prepare a hybrid nanostructure formed of nitrogen-doped Ketjenblack carbon (N-KC) supported Co3O4 nanoparticles (Co3O4/N-KC), which could be used as a promising and stable electrocatalyst for ORR. Compared with the physical mixture of Co3O4 and N-KC and pure N-KC samples, the resulting Co3O4/N-KC nanohybrid afforded remarkably superb ORR activity with a half-wave potential of 0.82 V (vs. reversible hydrogen electrode, RHE) and a limiting current density of 5.70 mA cm-2 in KOH solution (0.1 M). Surprisingly, the Co3O4/N-KC sample possessed a similar electrocatalytic activity but better durability to the 20 wt% Pt/C catalyst. The remarkable ORR activity of the Co3O4/N-KC nanohybrid was mainly due to the strong coupling effect between Co3O4 and N-KC, the N species dopant, high electroconductivity, and the large BET surface area. Our work enlightens the exploitation of advanced Co3O4/carbon hybrid material alternative to the Pt-based electrocatalysts.

Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.

BACKGROUND: Proteolytic cleavage of protease-activated receptor 1 (PAR1) can result in potent downstream regulatory effects on inflammation. Although PAR1 is expressed throughout the gastrointestinal tract and activating proteases are increased in inflammatory bowel disease, the effect of PAR1 activation on colitis remains poorly understood, and has not previously been studied in pediatric disease. METHODS: Expression of PAR1 and inflammatory cytokines in colonic biopsies from pediatric patients with Crohn's disease exhibiting active moderate to severe colitis was measured by quantitative PCR. The functional relevance of these clinical data was further studied in a mouse model of Citrobacter rodentium-induced colitis. RESULTS: PAR1 expression was significantly upregulated in the inflamed colons of pediatric patients with Crohn's disease, with expression levels directly correlating to disease severity. In patients with severe colitis, PAR1 expression uniquely correlated with Th17-related (IL17A, IL22, and IL23A) cytokines. Infection of PAR1-deficient (PAR1) and wildtype mice with colitogenic C. rodentium revealed that disease severity and colonic pathology were strongly attenuated in mice lacking PAR1. Furthermore, Th17-type immune response was completely abolished in the colons of infected PAR1 but not wildtype mice. Finally, PAR1 was shown to be essential for secretion of the Th17-driving cytokine IL-23 by C. rodentium-stimulated macrophages. CONCLUSIONS: This study demonstrates a strong link between PAR1 expression, Th17-type immunity, and disease severity in both pediatric patients with Crohn's disease and C. rodentium-induced colitis in mice. The data presented suggest PAR1 exerts a proinflammatory role in colitis in both humans and mice by promoting a Th17-type immune response, potentially by supporting the production of IL-23.

Activation of TRIF-dependent and independent immune responses by neisserial heat shock protein complex vaccines.

ASBTRACT Heat shock protein Complex (HspC) vaccines are composed of Hsp purified from pathogenic bacteria along with their chaperoned protein cargo. Mouse studies have shown that HspC vaccines can induce a strong immune response against pathogenic bacteria without addition of an exogenous adjuvant. These vaccines are now entering clinical trials. It was predicted, but not previously tested, that HspC vaccines induce an immune response due to the activation of Toll-Like Receptors (TLR) by their component Hsp. Recently we tested this supposition and found that while this held true for the cellular response to neisserial HspC vaccines, strong antigen-specific antibody responses were surprisingly generated in mice deficient in MyD88 and thus most TLR signaling. This suggested an unidentified mechanism by which HspC vaccines induce an antibody response. We have now examined the antigenic profile of this response and found no evidence that this is due to the induction of T-independent antibodies. Examination of the MyD88-dependent signaling pathways involved in the cellular response to neisserial HspC showed that both TRIF-dependent and TRIF-independent pathways are activated, each resulting in the secretion of different cytokines. Hence the mechanism of action of HspC vaccines is clearly more complicated than originally thought.

ß-Cyclodextrin functionalized polystyrene porous monoliths for separating phenol from wastewater.

A ß-cyclodextrin (ß-CD) functionalized polystyrene porous monolith was prepared by the following procedure: First, ß-CD was modified with allyl bromide leading to allyl-ß-cyclodextrin (allyl-ß-CD); then a concentrated emulsion was prepared using a mixture of allyl-ß-CD, styrene, and divinyl benzene as the continuous phase and water as the dispersed phase. In the third step, a ß-cyclodextrin (ß-CD) functionalized polystyrene porous monolith was obtained by copolymerization of allyl-ß-CD and styrene followed by removal of the water phase. Since the allyl-ß-CD contained both hydrophilic and hydrophobic groups, it tended to move towards the water/oil interface. As a result, the internal surfaces of the porous monolith were enriched with ß-CD. This enrichment was indicated by X-ray photoelectron spectroscopy characterization. The high content of ß-CD and the high specific surface area of the porous monolith both contributed to a high adsorption capacity. For example, the maximum adsorption of phenol was 5.74 mg/g. Importantly, the porous monolith could be easily regenerated and recycled through desorption with ethanol and it was found that the adsorption properties remained stable for at least five adsorption/desorption cycles.

Fabrication of interfacial functionalized porous polymer monolith and its adsorption properties of copper ions.

The interfacial functionalized poly (glycidyl methacrylate) (PGMA) porous monolith was fabricated and applied as a novel porous adsorbent for copper ions (Cu(2+)). PGMA porous material with highly interconnected pore network was prepared by concentrated emulsion polymerization template. Then polyacrylic acid (PAA) was grafted onto the interface of the porous monolith by the reaction between the epoxy group on PGMA and a carboxyl group on PAA. Finally, the porous monolith was interfacial functionalized by rich amount of carboxyl groups and could adsorb copper ions effectively. The chemical structure and porous morphology of the porous monolith were measured by Fourier transform infrared spectroscopy and scanning electron microscopy. Moreover, the effects of pore size distribution, pH value, co-existing ions, contacting time, and initial concentrations of copper ions on the adsorption capacity of the porous adsorbents were studied.

Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant.

BACKGROUND: The development of a vaccine against the human gastric pathogen Helicobacter pylori, the main causative agent of gastric adenocarcinoma, has been hampered by a number of issues, including the lack of a mucosal adjuvant for use in humans. Heat shock proteins (Hsp), highly conserved molecules expressed by both bacteria and mammalian species, possess a range of functions, including acting as chaperones for cellular proteins and the ability to activate innate immune receptors. Hsp complex (HspC) vaccines, containing Hsp derived from pathogenic bacteria, are immunostimulatory without addition of an exogenous adjuvant and can induce immunity against their chaperoned proteins. In this study we explored in mice the potential utility of a H. pylori HspC vaccine. RESULTS: Vaccination with H. pylori HspC, by either the subcutaneous or respiratory mucosal route, induced a strong antibody response, elevated gastric cytokine levels and significant protection against subsequent live challenge with this pathogen. The level of protection induced by non-adjuvanted HspC vaccine was equivalent to that which resulted from vaccination with adjuvanted vaccines. While protection induced by immunisation with adjuvanted vaccines was associated with the development of a moderate to severe atrophic gastritis, that induced by H. pylori HspC only resulted in a mild inflammatory response, despite an increase in pro-inflammatory gastric cytokines. This reduced gastritis correlated with an increase in IL-10 and IL-13 levels in the gastric tissues of HspC vaccinated, H. pylori challenged mice. CONCLUSIONS: H. pylori HspC vaccines have the potential to overcome some of the issues preventing the development of a human vaccine against this pathogen: HspC induced protective immunity against H. pylori without addition of an adjuvant and without the induction of a severe inflammatory response. However, complete protection was not obtained so further optimisation of this technology is needed if a human vaccine is to become a reality.